Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today
reported results for the three and six months ended June 30, 2021.
Results are presented in Canadian dollars unless otherwise noted.
Second Quarter Highlights
- Continuing growth in vaccination
levels among residents and staff, providing enhanced protection
across our network.
- No current outbreaks in our
long-term care (LTC) homes or retirement communities.
- LTC occupancy up 250 bps as COVID
restrictions ease.
- Maintaining enhanced staffing
levels, testing and other prevention measures as emergence of COVID
variants remain a concern.
- Home health care average daily
volumes increase 3.7% and return to pre-pandemic levels.
“As the impact of the pandemic receded, we experienced a broad
recovery across Extendicare in the second quarter, with strong
growth in both LTC occupancy and home health care volumes,” said
President and Chief Executive Officer, Dr. Michael Guerriere. “We
are gratified by the outstanding efforts of our staff to get
vaccinated to protect themselves and those we care for. Our
comprehensive resident and staff vaccination program has enabled us
to welcome families and visitors back into our LTC homes and
retirement communities in recent weeks. While we are encouraged by
the progress made this quarter, we continue to maintain enhanced
staffing levels in our homes, accompanied by robust testing and
other prevention measures, to complement the success of the
vaccines. We remain vigilant as a resurgence in COVID-19 cases
cannot be ruled out until there is broader progress on vaccination
rates in the general population.”
Protecting Residents, Clients and
Caregivers
As of August 5, 2021, Extendicare has no active outbreaks across
its 69 LTC homes and retirement communities.
Extendicare’s extensive education and awareness campaign for
staff, along with the provision of paid time off and reimbursement
of travel expenses for vaccination, are contributing to rising
vaccination rates that are helping to keep our residents and
employees safe and keep the virus out of our LTC homes and
retirement communities. Our vaccination rates as of August 5th were
as follows:
- 92% of our LTC and 90% of our
retirement residents have been fully vaccinated;
- 86% of our LTC staff and 80% of our
retirement staff have received at least their first dose; and
- 86% of ParaMed staff have received
at least their first dose.
More of our staff are being vaccinated each week. We continue to
conduct active symptom screening upon entry and continued use of
personal protective equipment. Surveillance testing continues to
play an important role in keeping our homes and communities safe –
now with a particular focus on those who are not yet fully
vaccinated.
With the marked decrease in COVID-19 outbreaks in Q2 2021, our
pandemic related spending decreased to $42.8 million from $58.1
million in Q1 2021. These costs were partially offset by provincial
funding of $33.3 million. These costs included $11.3 million in
temporary pandemic pay premiums for eligible front-line staff in Q2
2021, offset by funding from Ontario and Alberta. Since the
beginning of the pandemic, unfunded pandemic costs have resulted in
a cumulative reduction of Adjusted EBITDA of $41.9 million. While
COVID-19 costs declined in Q2 2021, we will continue to incur
elevated costs as we remain vigilant in our on-going efforts to
protect our residents, clients and staff until the threat of the
pandemic has abated. The amount and timing of COVID-19 funding has
not always aligned with when costs are incurred causing significant
volatility in our results, which we expect will continue until the
pandemic subsides.
Extendicare is also investing to meet the needs of residents and
clients in the future. During Q2 2021, construction commenced on
Extendicare’s new 192-bed LTC home in Kingston, Ontario, while
construction on our new Sudbury, Ontario home continued. In Q2
2021, we successfully closed $95.9 million in construction
financing to support the Sudbury and Kingston projects.
In our ongoing efforts to address the significant staffing
challenges facing the industry, we continue to make progress with
our PSW college partnerships and in-house HSW training programs,
graduating and hiring more than 300 new caregivers through these
programs in the first half of 2021. We are also participating in
various new federal and provincial programs aimed at expanding the
seniors’ care workforce, with more than 250 students enrolled in
internships to whom we plan to offer employment upon
graduation.
Q2 2021 Financial Highlights (all comparisons
with Q2 2020)
- Revenue up 9.0% or $25.5 million to
$307.4 million; driven by a 24.0% increase in home health care
average daily volumes (ADV), COVID-19 funding of $6.1 million, LTC
funding enhancements and growth in retirement living and other
operations, partially offset by timing of flow-through funding, and
lower preferred accommodation revenue in LTC operations.
- Net operating income (NOI)(1) up
$11.3 million to $31.3 million; reflecting the Canada Emergency
Wage Subsidy (CEWS) payments to ParaMed of $7.7 million, increased
ADV and back-office efficiencies in home health care operations and
a reduction in net COVID-19 costs of $1.1 million, partially offset
by increased costs of resident care and lower preferred
accommodation revenue in LTC operations.
- Adjusted EBITDA(1) up $9.7 million
to $17.8 million; reflecting the improvement in NOI noted above and
$0.1 million reduction in COVID-19 related administrative costs,
partially offset by higher administrative costs related to labour,
information technology, professional fees and travel.
- Earnings from continuing operations
up $9.8 million to $1.0 million; primarily driven by improvements
in NOI from the home health care operations, lower finance costs
and other expense recorded in Q2 2020, partially offset by higher
administrative costs.
- AFFO(1) of $8.1 million ($0.09 per
basic share), up $5.1 million; reflecting the increase in earnings
from continuing operations, excluding the other expense recorded in
Q2 2020, partially offset by higher maintenance capex.
Six Months 2021 Financial Highlights (all
comparisons with Six Months 2020)
- Revenue up 13.7% or $76.1 million to
$629.8 million; driven by COVID-19 funding of $61.5 million, a
10.1% increase in home health care ADV, LTC funding enhancements
and growth in retirement living and other operations, partially
offset by timing of flow-through funding and lower preferred
accommodation revenue in LTC operations.
- NOI up $21.2 million to $71.5
million; reflecting CEWS payments received by ParaMed of $17.4
million, increased ADV and back-office efficiencies in home health
care and growth in other operations, partially offset by increased
costs of resident care and lower preferred accommodation revenue in
LTC operations.
- Adjusted EBITDA up $17.2 million to
$45.5 million; reflecting the improvement in NOI noted above,
partially offset by higher administrative costs related to labour,
information technology, professional fees, travel, insurance and
claims reserves, and COVID-19 administrative costs of $0.8
million.
- Earnings from continuing operations
up $16.9 million to $9.3 million; primarily driven by improvements
in NOI from the home health care and other operations segments, and
lower finance costs and other expense, partially offset by higher
administrative costs.
- AFFO of $27.6 million ($0.31 per
basic share), up $13.0 million; reflecting the increase in earnings
from continuing operations, excluding the other expense recorded in
2020, partially offset by higher maintenance capex.
Business Updates
The following is a summary of the Company’s revenue, NOI and NOI
margins by business segment for the three and six months ended June
30, 2021 and 2020, respectively.
(unaudited) |
Three months ended June 30 |
|
|
Six months ended June 30 |
|
(millions of dollars, |
|
|
2021 |
|
|
|
|
2020 |
|
|
|
|
2021 |
|
|
|
|
2020 |
|
unless
otherwise noted) |
Revenue |
NOI |
Margin |
|
|
Revenue |
NOI |
Margin |
|
|
Revenue |
NOI |
Margin |
|
|
Revenue |
NOI |
Margin |
|
Long-term care |
187.2 |
9.8 |
5.2 |
% |
|
178.5 |
11.1 |
6.2 |
% |
|
392.3 |
26.1 |
6.6 |
% |
|
338.7 |
29.5 |
8.7 |
% |
Retirement living |
12.3 |
3.7 |
30.1 |
% |
|
11.7 |
3.5 |
30.0 |
% |
|
24.5 |
7.1 |
29.2 |
% |
|
23.8 |
7.2 |
30.4 |
% |
Home health care |
101.1 |
14.0 |
13.9 |
% |
|
85.5 |
1.4 |
1.7 |
% |
|
198.8 |
30.0 |
15.1 |
% |
|
178.6 |
5.7 |
3.2 |
% |
Other |
6.9 |
3.7 |
54.2 |
% |
|
6.3 |
3.9 |
62.0 |
% |
|
14.3 |
8.3 |
58.1 |
% |
|
12.7 |
7.8 |
61.4 |
% |
|
307.4 |
31.3 |
10.2 |
% |
|
281.9 |
19.9 |
7.1 |
% |
|
629.8 |
71.5 |
11.4 |
% |
|
553.8 |
50.3 |
9.1 |
% |
Note: Totals may not sum due to
rounding. |
Long-Term Care
Lower rates of COVID-19 cases and an easing of restrictions
during Q2 2021 resulted in an increase in admissions to our LTC
homes. Average occupancy in our LTC homes recovered 250 bps to
85.4% in Q2 2021 from 82.9% in Q1 2021, down from 93.5% in Q2 2020.
With lengthy waitlists for LTC in many of the communities where
Extendicare operates, we expect average occupancy levels to
continue to increase as long as rates of COVID-19 in the community
remain low. Despite lower occupancy levels, our revenue base was
largely preserved through basic occupancy protection funding from
the Government of Ontario, which continues until August 31, 2021.
Each of the western provinces where we operate have also introduced
additional funding to offset the impact of COVID-19, some of which
includes funding to address occupancy shortfalls.
Increased costs to protect our staff and residents and lower
preferred accommodation revenue resulted in lower NOI and NOI
margin compared to the same period last year. NOI and NOI margin in
Q2 2021 were $9.8 million and 5.2%, respectively, down from $11.1
million and 6.2% respectively in Q2 2020. Compared to Q2 2020,
COVID-19 related funding increased by $7.9 million, resulting in a
$1.4 million reduction in unfunded costs associated with COVID-19
and pandemic pay programs.
Home Health Care
Extendicare’s home health care volumes returned to pre-pandemic
levels as we exited Q2 2021. Our Q2 2021 ADV was 25,264, up 3.7%
from Q1 2021 and 24.0% higher than Q2 2020.
In Q2 2021, ParaMed’s revenue was $101.1 million, up 18.3% from
Q2 2020, driven by growth in ADV of 24.0%, partially offset by
lower COVID-19 and pandemic pay funding of $1.8 million.
NOI and NOI margin increased to $14.0 million and 13.9%,
respectively, in Q2 2021, up from $1.4 million and 1.7%,
respectively, in Q2 2020. The improvement in NOI reflects CEWS
payments received by ParaMed of $7.7 million in Q2 2021, higher ADV
and improved back-office efficiencies. This was offset by an
increase in net costs associated with COVID-19 of $0.6 million.
Given the level of recovery in ADV, we do not anticipate qualifying
for CEWS in future quarters.
Excluding the impact of CEWS, net COVID-19 related costs and Q4
2020 one-time charges, NOI margins continue to improve with Q2 2021
at 7.9%, as compared to 7.3% in Q1 2021 and 5.8% in Q4 2020.
Retirement Living
The financial performance of our retirement living operations
improved over Q2 2020, as easing of COVID-19 restrictions began to
positively impact occupancy and care services.
In Q2 2021, higher revenue of $0.6 million or 4.8% and lower
estimated net COVID-19 costs, partially offset by increased labour
and promotional costs, contributed to an increase in NOI of $0.2
million or 5.2% from Q2 2020.
Throughout the pandemic the average occupancy of our stabilized
communities has remained above 90%. The easing of restrictions
during the latter half of the second quarter contributed to an
increase in average occupancy of 30 bps to 84.4% in Q2 2021 from Q1
2021 comprised of an increase of 210 bps in our lease-up
communities, partially offset by a 50 bps decrease in our
stabilized communities.
Other Operations
Increased customer demand contributed to continued solid
performance in our SGP Purchasing Partner Network (SGP).
Investments in growth initiatives, including higher promotional and
travel expenses, impacted NOI and NOI margins in the quarter.
Revenue increased to $6.9 million, up 9.8% from Q2 2020, largely
driven by customer growth in SGP. Increased operating costs in the
quarter resulted in a decline in NOI by $0.2 million or 4.0% to
$3.7 million, representing 54.2% of revenue. The number of
third-party residents served by SGP increased to approximately
83,500 at the end of Q2 2021, up 11.1% from Q2 2020 and 3.0% from
Q1 2021.
Financial Position
As at June 30, 2021, Extendicare had cash and cash equivalents
on hand of $132.5 million and access to a further $73.2 million in
undrawn demand credit facilities. In addition, the Company has
construction financing in the aggregate of $95.9 million available
for its Sudbury and Kingston LTC redevelopment projects. As a
result, Extendicare is well positioned with strong liquidity and no
scheduled debt maturities until Q1 2022.
Select Financial Information
The following is a summary of the Company’s consolidated
financial information for the three and six months ended June 30,
2021 and 2020.
(unaudited) |
Three months ended June 30 |
|
|
Six months ended June 30 |
|
(thousands of dollars unless otherwise noted) |
2021 |
|
2020 |
|
|
2021 |
|
2020 |
|
Revenue |
307,449 |
|
281,947 |
|
|
629,830 |
|
553,765 |
|
Operating expenses |
276,198 |
|
262,013 |
|
|
558,315 |
|
503,448 |
|
NOI (1) |
31,251 |
|
19,934 |
|
|
71,515 |
|
50,317 |
|
NOI margin (1) |
10.2 |
% |
7.1 |
% |
|
11.4 |
% |
9.1 |
% |
Administrative costs |
13,434 |
|
11,767 |
|
|
25,975 |
|
22,019 |
|
Adjusted EBITDA (1) |
17,817 |
|
8,167 |
|
|
45,540 |
|
28,298 |
|
Adjusted EBITDA margin (1) |
5.8 |
% |
2.9 |
% |
|
7.2 |
% |
5.1 |
% |
Other
expense |
− |
|
2,780 |
|
|
− |
|
2,780 |
|
Earnings from continuing operations |
960 |
|
(8,889 |
) |
|
9,283 |
|
(7,652 |
) |
per basic and diluted share ($) |
0.01 |
|
(0.10 |
) |
|
0.10 |
|
(0.09 |
) |
Earnings from discontinued operations, net of
tax |
− |
|
5,230 |
|
|
− |
|
9,899 |
|
Net earnings |
960 |
|
(3,659 |
) |
|
9,283 |
|
2,247 |
|
per basic and diluted share ($) |
0.01 |
|
(0.04 |
) |
|
0.10 |
|
0.03 |
|
AFFO (1) |
8,073 |
|
2,946 |
|
|
27,618 |
|
14,576 |
|
per basic share ($) |
0.09 |
|
0.03 |
|
|
0.31 |
|
0.16 |
|
per diluted share ($) |
0.09 |
|
0.03 |
|
|
0.30 |
|
0.16 |
|
Current income tax expense included in FFO |
2,091 |
|
(1,848 |
) |
|
4,918 |
|
225 |
|
FFO effective tax rate |
24.7 |
% |
140.9 |
% |
|
18.3 |
% |
2.3 |
% |
Maintenance capex |
3,746 |
|
2,157 |
|
|
4,779 |
|
3,912 |
|
Cash dividends declared per share |
0.12 |
|
0.12 |
|
|
0.24 |
|
0.24 |
|
Payout ratio (1) |
133 |
% |
365 |
% |
|
78 |
% |
147 |
% |
Weighted average number of shares (thousands) |
|
|
|
|
|
Basic |
89,980 |
|
89,826 |
|
|
89,954 |
|
89,735 |
|
Diluted |
100,615 |
|
100,177 |
|
|
100,672 |
|
100,095 |
|
(1) Non-GAAP Measures: Extendicare assesses
and measures operating results and financial position based on
performance measures referred to as “net operating income”, “NOI”,
“NOI margin”, “Adjusted EBITDA”, “Adjusted EBITDA margin”, “AFFO”,
“AFFO per share”, and “payout ratio”. In addition, the Company
assesses its return on investment in development activities using
the non-GAAP financial measure “NOI Yield”. These measures are not
recognized under GAAP and do not have standardized meanings
prescribed by GAAP. These non-GAAP measures are presented in this
document because either: (i) management believes that they are a
relevant measure of Extendicare’s operating performance and ability
to pay cash dividends; or (ii) certain ongoing rights and
obligations of Extendicare may be calculated using these measures.
Such non-GAAP measures may differ from similar computations as
reported by other issuers and, accordingly, may not be comparable
to similarly titled measures as reported by such issuers. They are
not intended to replace earnings (loss) from continuing operations,
net earnings (loss), cash flow, or other measures of financial
performance and liquidity reported in accordance with GAAP.
Detailed descriptions of these terms can be found in Extendicare’s
disclosure documents, including its Management’s Discussion and
Analysis, filed with the securities regulatory authorities; these
documents are available at www.sedar.com and on Extendicare’s
website at www.extendicare.com. |
Extendicare’s disclosure documents, including its Management’s
Discussion and Analysis, may be found on SEDAR’s website at
www.sedar.com under the Company’s issuer profile and on the
Company’s website at www.extendicare.com under the
“Investors/Financial Reports” section.
August Dividend Declared
The Board of Directors of Extendicare today declared a cash
dividend of $0.04 per share for the month of August 2021, which is
payable on September 15, 2021, to shareholders of record at the
close of business on August 31, 2021. This dividend is designated
as an “eligible dividend” within the meaning of the Income Tax Act
(Canada).
Conference Call and Webcast
On August 6, 2021, at 11:30 a.m. (ET), Extendicare will hold a
conference call to discuss its 2021 second quarter results. The
call will be webcast live and archived online at
www.extendicare.com under the “Investors/Events &
Presentations” section. Alternatively, the call-in number is
1-800-319-4610 or 416-915-3239. A replay of the call will be
available approximately two hours after completion of the live call
until midnight on August 20, 2021. To access the rebroadcast dial
1-800-319-6413 followed by the passcode 7326#.
About Extendicare
Extendicare is a leading provider of care and services for
seniors across Canada, operating under the Extendicare, Esprit
Lifestyle, ParaMed, Extendicare Assist, and SGP Purchasing Partner
Network brands. We are committed to delivering quality care
throughout the health continuum to meet the needs of a growing
seniors population. We operate or provide contract services to a
network of 120 long-term care homes and retirement communities (69
owned/51 contract services), provide approximately 8.8 million
hours of home health care services annually, and provide group
purchasing services to third parties representing approximately
83,500 senior residents across Canada. Extendicare proudly employs
more than 23,500 qualified, highly trained and dedicated
individuals who are passionate about providing high quality care
and services to help people live better.
Forward-looking Statements
This press release contains forward-looking statements
concerning anticipated future events, results, circumstances,
economic performance or expectations with respect to Extendicare
and its subsidiaries, including, without limitation, statements
regarding its business operations, business strategy, growth
strategy, results of operations and financial condition, including
anticipated timelines, costs and financial returns in respect of
development projects, and in particular statements in respect of
the impact of measures taken to mitigate the impact of COVID-19,
the availability of various government programs and financial
assistance announced in respect of COVID-19, the impact of COVID-19
on the Company’s operating costs, staffing, procurement, occupancy
levels and volumes in its home health care business, the impact on
the capital and credit markets and the Company’s ability to access
the credit markets as a result of COVID-19, increased litigation
and regulatory exposure and the outcome of any litigation and
regulatory proceedings. Forward-looking statements can often be
identified by the expressions “anticipate”, “believe”, “estimate”,
“expect”, “intend”, “objective”, “plan”, “project”, “will” or other
similar expressions or the negative thereof. These forward-looking
statements reflect the Company’s current expectations regarding
future results, performance or achievements and are based upon
information currently available to the Company and on assumptions
that the Company believes are reasonable. The Company assumes no
obligation to update or revise any forward-looking statement,
except as required by applicable securities laws. These statements
are not guarantees of future performance and involve known and
unknown risks, uncertainties and other factors that may cause
actual results, performance or achievements of the Company to
differ materially from those expressed or implied in the
statements. In particular, risks and uncertainties related to the
effects of COVID-19 on the Company include the length, spread and
severity of the pandemic; the nature and extent of the measures
taken by all levels of governments and public health officials,
both short and long term, in response to COVID-19; domestic and
global credit and capital markets; the Company’s ability to access
capital on favourable terms or at all due to the potential for
reduced revenue and increased operating expenses as a result of
COVID-19; the availability of insurance on favourable terms;
litigation and/or regulatory proceedings against or involving the
Company, regardless of merit; the health and safety of the
Company’s employees and its residents and clients; and domestic and
global supply chains, particularly in respect of personal
protective equipment. Given the evolving circumstances surrounding
COVID-19, it is difficult to predict how significant the adverse
impact will be on the global and domestic economy and the business
operations and financial position of Extendicare. For further
information on the risks, uncertainties and assumptions that could
cause Extendicare’s actual results to differ from current
expectations, refer to “Risk Factors” in Extendicare’s Annual
Information Form and “Forward Looking-Statements” in Extendicare’s
Q2 2021 Management’s Discussion and Analysis filed by Extendicare
with the securities regulatory authorities, available at
www.sedar.com and on Extendicare’s website at www.extendicare.com.
Given these risks and uncertainties, readers are cautioned not to
place undue reliance on Extendicare’s forward-looking
statements.
Extendicare contact:David Bacon, Senior Vice
President and Chief Financial OfficerPhone: (905) 470-4000; Fax:
(905) 470-5588Email:
david.bacon@extendicare.comwww.extendicare.com
Extendicare (TSX:EXE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Extendicare (TSX:EXE)
Historical Stock Chart
From Jul 2023 to Jul 2024